全文获取类型
收费全文 | 42120篇 |
免费 | 2216篇 |
国内免费 | 141篇 |
专业分类
耳鼻咽喉 | 547篇 |
儿科学 | 2682篇 |
妇产科学 | 749篇 |
基础医学 | 4948篇 |
口腔科学 | 1343篇 |
临床医学 | 3043篇 |
内科学 | 7640篇 |
皮肤病学 | 1177篇 |
神经病学 | 2496篇 |
特种医学 | 1296篇 |
外科学 | 6322篇 |
综合类 | 1317篇 |
一般理论 | 18篇 |
预防医学 | 2117篇 |
眼科学 | 1597篇 |
药学 | 4087篇 |
1篇 | |
中国医学 | 359篇 |
肿瘤学 | 2738篇 |
出版年
2023年 | 340篇 |
2022年 | 1005篇 |
2021年 | 1674篇 |
2020年 | 925篇 |
2019年 | 1005篇 |
2018年 | 1434篇 |
2017年 | 1034篇 |
2016年 | 1379篇 |
2015年 | 1396篇 |
2014年 | 2046篇 |
2013年 | 2350篇 |
2012年 | 3292篇 |
2011年 | 3206篇 |
2010年 | 1956篇 |
2009年 | 1511篇 |
2008年 | 2167篇 |
2007年 | 2205篇 |
2006年 | 2001篇 |
2005年 | 1767篇 |
2004年 | 1649篇 |
2003年 | 1395篇 |
2002年 | 1202篇 |
2001年 | 839篇 |
2000年 | 771篇 |
1999年 | 655篇 |
1998年 | 283篇 |
1997年 | 232篇 |
1996年 | 230篇 |
1995年 | 202篇 |
1994年 | 160篇 |
1993年 | 138篇 |
1992年 | 381篇 |
1991年 | 361篇 |
1990年 | 377篇 |
1989年 | 352篇 |
1988年 | 318篇 |
1987年 | 264篇 |
1986年 | 257篇 |
1985年 | 250篇 |
1984年 | 189篇 |
1983年 | 128篇 |
1982年 | 72篇 |
1981年 | 79篇 |
1980年 | 75篇 |
1979年 | 119篇 |
1978年 | 77篇 |
1977年 | 92篇 |
1976年 | 69篇 |
1973年 | 66篇 |
1971年 | 65篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Apoorva Challa Neeraj Mahajan Seema Sood Arti Kapil Bimal Kumar Das Vishnubhatla Sreenivas Somesh Gupta 《Indian journal of medical microbiology》2022,40(3):433-435
Treatment guidelines for management of uncomplicated gonorrhoeae have been recently modified owing to alarming upsurge in azithromycin resistance. This study investigated the prevalence and genetic determinants of gonococcal azithromycin resistance in India. Four (5.7%) of 70 gonococcal isolates were resistant to azithromycin. Of 16 isolates investigated for molecular mechanisms of resistance, 13 (81.3%) and 6 (37.5%) isolates exhibited mutations in coding and promoter regions of mtrR gene, respectively. However, ermA, ermB and ermC genes or mutations in rrl gene were absent in all isolates. Azithromycin resistance is low in India posing no immediate threat to use of dual-therapy for syndromic management. 相似文献
2.
3.
B Maybury A Powell-Chandler N Kumar 《Annals of the Royal College of Surgeons of England》2015,97(3):e37-e38
We report two British cases of liver abscess, due to Klebsiella pneumoniae and associated with synchronous infection elsewhere, which required liver resection for definitive treatment. They illustrate the geographic spread of aggressive K pneumoniae liver infection and demonstrate the importance of early aggressive treatment. 相似文献
4.
Monique G. Kumar M.Phil. M.D. Heather Ciliberto M.D. Susan J. Bayliss M.D. 《Pediatric dermatology》2015,32(2):198-200
Pediatric trachyonychia is an acquired nail disease that can cause distress to families. It is a poorly understood disease, and long‐term follow‐up data are lacking. We present an institutional review of 11 children with isolated pediatric trachyonychia followed over time. Children with the diagnosis of pediatric trachyonychia were identified and invited to participate. Pictures were taken on follow‐up and a questionnaire was answered. Exclusion criteria include having another diagnosis at the initial visit that causes nail dystrophy. Eleven patients with the diagnosis of pediatric trachyonychia were available for follow‐up. The mean age of appearance was 2.7 years (range 2–7 yrs) and the average follow‐up was 66 months (range 10–126 mos). Nine patients were treated with potent topical corticosteroids, one used only petrolatum, and one took vitamin supplements. One patient was found to have an additional skin and hair diagnosis of alopecia areata on follow‐up. On follow‐up, 82% noted improvement of the nails, whereas 18% noted no change. A majority of cases of pediatric trachyonychia are isolated and improve with time, regardless of treatment. 相似文献
5.
6.
7.
8.
9.
Aditya Kelkar Caroll Webers Rohit Shetty Jai Kelkar Nikhil Labhsetwar Abhishek Pandit Madhulika Malode Sayali Tidke 《Indian journal of ophthalmology》2020,68(10):2143
Purpose:To evaluate the rate of compliance and the reasons for loss to follow-up in Indian patients with diabetic macular edema (DME), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) being treated with anti-vascular endothelial growth factor (VEGF) therapy.Methods:This was a retrospective single-center study. Patients with DME, AMD, or RVO were eligible if they initiated anti-VEGF therapy between January 2013 and December 2017. Patients'' data were obtained from hospital electronic records, including the number of injections received, visits, details of follow-up, missed appointments, and reasons for loss to follow-up (>365 days).Results:A total of 648 patients were eligible for the study, of which 334 (51.54%) patients were lost to follow-up. Overall, 343 (64.96%) were males and the overall mean (SD) age was 66.40 (7.44) years. A total of 376 (58.0%) patients had a history of diabetes and 364 (56.2%) patients had a history of hypertension. Further, 127 (38.0), 112 (33.5), and 95 (28.4) had DME, AMD, and RVO, respectively and were lost to follow-up. The most commonly reported reason for loss to follow-up was “non-affordability” (n = 120; 41.1%) followed by “no improvement in vision” (n = 83; 28.4%). “No improvement in vision” (42.2%) and “non-affordability” (37.5%) were higher among patients with DME. No association was found in gender- and treatment-wise distribution of reasons for loss to follow-up.Conclusion:The results showed that around half of the patients with DME, AMD, and RVO were lost to follow-up to intravitreal anti-VEGF therapy, and the most common factors were “non-affordability” and “no improvement in vision.” 相似文献